Research Article
γ-H2AX: A Novel Prognostic Marker in a Prognosis Prediction Model of Patients with Early Operable Non-Small Cell Lung Cancer
Table 2
Selected input variables by the parameter-increasing method.
| Order of
selection | 1-year survival | 3-year survival | 4-year survival | | | ANN | LR | ANN | LR | ANN | LR |
| | 1 | High expression of
-H2AX | High expression
of γ-H2AX | High expression of
Ki67 | High expression of Ki67 | Age | N2 number | | 2 | High expression of
caspase 3 | Chemotherapy adjuvant | High expression of
caspase 3 | | Histology | Histology | | 3 | First metastasis | Radiotherapy adjuvant | N1 number | | Grade | Border of
bronchus | | 4 | High expression of P53 | | Grade | | N | | | 5 | Gender | | High expression of P53 | | Radiotherapy adjuvant | | | 6 | | | | | High expression of
caspase 3 | | | 7 | | | | | High expression of
-H2AX | | | 8 | | | | | Fev1 < 70% | | | 9 | | | | | High expression of P53 | |
|
|
